Compare ACV & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACV | NRC |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.3M | 278.8M |
| IPO Year | N/A | N/A |
| Metric | ACV | NRC |
|---|---|---|
| Price | $26.83 | $18.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 38.8K | ★ 89.9K |
| Earning Date | 01-01-0001 | 01-26-2026 |
| Dividend Yield | ★ 9.20% | 3.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | N/A | ★ $139,102,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.82 | $9.76 |
| 52 Week High | $23.74 | $19.39 |
| Indicator | ACV | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 67.06 | 65.79 |
| Support Level | $25.30 | $18.50 |
| Resistance Level | $26.76 | $19.20 |
| Average True Range (ATR) | 0.35 | 0.73 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 90.79 | 83.81 |
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.